World News – CA – Can Industrial REITs Make The Most Of This Cyber ​​Monday?

When Thanksgiving celebrates the abundance of nature, retailers can sell abundantly on Black Friday and Cyber ​​Monday, as well as the following month. And even if the year was particularly difficult, with the pandemic causing both health and financial problems, people are leaving their worries behind with vaccination hopes and buying things, at least online, which is undoubtedly encouraging. Obviously, the pandemic has fueled online orders and significantly increased the share of e-commerce in total retail sales. Even the hesitant, who used to prefer in-store shopping, now prefer to shop online to avoid physical contact and the spread of infection. As a result, Black Friday, which is essentially a day for visits to physical stores, went online this year. Quite a number of consumers preferred the virtual retail channel amid the pandemic.

According to Adobe Analytics, American consumers spent $ 9 billion online after Thanksgiving on Black Friday. Not only does that represent a nearly 22% year-over-year increase, but it also makes Black Friday 2020 the second-largest online spending day in the country’s history, and just behind last year’s Cyber ​​Monday. What’s more encouraging is that Cyber ​​Monday 2020 is set to be the biggest online shopping festival of all time, and spending is expected to hit a whopping $ 10. 8- $ 12. 7 billion, which is 15 to 35% year-over-year growth, according to a CNBC report.

Well, it’s no secret how the commercial property category has played a pivotal role in this growing e-commerce market in recent years, changing the way consumers shop and receive their goods. Services such as same-day delivery are growing in importance, and last-mile properties in high-income urban areas saw solid prices, occupancy and rental growth. And the socially distant wave in the midst of this pandemic was the icing on the cake, fueling online orders and opening up opportunities for industrial landlords to develop. This asset class has indeed proven to be one of the few resilient property types amid the pandemic, with solid opportunities to move forward in the years to come. Aside from the rapid adoption of electronic retailing, industrial real estate is expected to benefit from a likely increase in inventory over the long term. This is because in response to the pandemic and trade disruptions, there is an opportunity to shift from a lean supply chain strategy to a more resilient one. This also ensures more security and the fuel for investments in this sector.

Prologis PLD is a leading industrial REIT that acquires, develops, operates and manages industrial real estate in the US and worldwide. The company continues to benefit from the size of its platform. Coupled with the rapid adoption of e-commerce, logistics properties are expected to benefit from a likely increase in inventory levels. Given Prologis’ capacity and solid balance sheet, it is well positioned to benefit from it. This Zacks Rank # 3 (Hold) company has a long term growth rate of 7. 9%. The Zacks consensus estimate for Funds from Operations (FFO) per share for the current year was 1. 1% north in the last two months to $ 3. 77. It also indicates an increase of 13. 9% compared to the previous year. Duke Realty Corp.. . DRE is a domestic pure industrial REIT that owns, manages, and develops commercial real estate in the United States. With around 159 million square meters of rentable industrial assets in 20 major logistics markets, this industrial REIT, currently ranked 3rd in Zacks, is likely to continue to see solid demand from e-commerce and traditional customers. The Zacks consensus estimate for 2020 and 2021 FFO per share was around 1. 3% and 2. Up 5% in the last few months to USD 1. 52 and $ 1. 63. The numbers also call for 5. 6% and 6. 8% growth over the previous year.

The full list of today’s Zacks # 1 Rank (Strong Buy) stocks can be found here. Rexford Industrial Realty REXR is focused on buying, owning and operating industrial real estate in Southern California’s in-fill markets. Zacks’ Consensus Estimate for 2020 and 2021 FFO per share for the Zacks Rank # 3 company has been revised 1. 6% and 3% up over the past 60 days to $ 1. 30 and $ 1. 38 each. This also shows an improvement of 5 over the previous year. 7% and 6. 2%. EastGroup Properties, Inc. . EGP focuses on the development, acquisition and operation of industrial real estate in key Sunbelt markets in the United States. The company places particular emphasis on states such as Florida, Texas, Arizona, California, and North Carolina. It is well positioned to benefit from the likely shift towards more inventory, faster population growth in Sunbelt markets, and increased demand for e-retail. Last month, the Zacks consensus estimate for the Zacks ranked 3 company’s FFO per share per share for 2020 and 2021 was revised up to $ 5. 36 and $ 5. 60 or. call for a growth of 7 over the previous year. 6% and 4. 4%. Here is the price movement of the above REITs over the past six months.

Note: Anything related to the returns presented in this description represents Funds from Operations (FFO) – a widely used metric used to measure the performance of REITs.

In the past year, sales were US $ 24 billion worldwide. It is projected to increase to $ 77 by 2020. 6 billion. Famed investor Mark Cuban says he will make « the world’s first trillionaires, » but that should leave plenty of money for regular investors who make the right trades early on. Check out the 3 best stocks in Zacks to play this trend >>

Would you like the latest recommendations from Zacks Investment Research? Today you can download 7 Best Stocks for the next 30 days. Click here to get this free report. Prologis, Inc. . (PLD): Free Stock Analysis Report Duke Realty Corporation (DRE): Free Stock Analysis Report EastGroup Properties, Inc. . (EGP): Free Stock Research Report Rexford Industrial Realty, Inc. . (REXR): Free Stock Analysis Report To read this article on Zacks. com click here. Zacks Investment Research

The Dow Jones Industrial Average fell more than 350 points on Monday amid the news of Moderna coronavirus vaccines. Tesla jumped to more all-time highs.

It’s been an impressive November for S&P 500 shares. And the month was another reminder of power in choosing top stocks.

I’ve read some of your HelpMeRetire inquiries and I have a situation that I don’t seem to find much information about from reading retirement planning guides. I am 60 years old and my spouse is 45 years old. Our cost of living isn’t extravagant, but we love to travel.

Where is the market headed from here after the wild ride of 2020? Much progress has been made in the COVID-19 vaccine race, but the short-term picture remains unclear as the virus resurgence and stimulus stalemate blur on Capitol Hill. In times like these, the big investors can serve as a source of inspiration, namely the billionaire Israel « Izzy » Englander. Who exactly is an Englishman? The legend, who began trading stocks in high school, began his career as an intern at the investment firm Oppenheimer. He later acquired a seat on the American stock exchange, where he acted as a floor broker, dealer and specialist. In 1989, Englander founded the Millennium Management hedge fund with Ronald Shear. As evidence of his stellar track record, the guru took the $ 35 million used to set up the fund into over $ 40 billion in assets under management. With his personal fortune of $ 7. No wonder Wall Street pays attention when Englander takes a step. With that in mind, our focus shifted to Millenium’s recent 13F filing, which reveals the stocks the fund bought in the third quarter. The TipRanks database recorded two tickers in particular and showed that both names achieve an analyst consensus of “Strong Buy”. In addition, the analyst community sees enormous upside potential for everyone. G1 Therapeutics (GTHX) With a deep understanding of cancer biology and extensive drug discovery experience, G1 Therapeutics develops therapies that can potentially improve the lives of patients battling the deadly disease. Before an important official decision is made, the street hits this name. In the third quarter, Englander and Millennium acquired a new stake in GTHX. When you pull the trigger for 555. Pressing 937 shares, the value of the stake is 6. 421. 000 USD. With regards to the analyst community, Needham’s Chad Messer tells his clients that he will be working before the PDUFA appointment for trilaciclib on Jan.. February, its therapy to improve outcomes for cancer patients treated with chemotherapy has high hopes. The NDA of therapy was accepted in August for priority review based on results from three randomized clinical trials in small cell lung cancer (SCLC). The FDA stated that no Advisory Council (AdComm) meeting is planned. Since trilaciclib is the first CDK4 / 6 inhibitor to be used to treat chemo-induced bone marrow toxicity, Messer argues that the absence of an AdComm makes “sense”. He then stated, “We believe this reflects the Agency’s appreciation for the unmet need, convenience with the safety profile of the CDK4 / 6 class, and the efficacy profile of trilaciclib. GTHX will also focus on adding trilaciclib to NCCN guidelines. It should also be noted that a pivotal phase 3 trial evaluating the candidate for metastatic colorectal cancer (mCRC) is scheduled to begin by the end of the year. In addition to the good news, GTHX and its partner Boehringer Ingelheim are preparing for the commercial launch of trilaciclib. The companies cover around 2. 500 attending oncologists and provide educational materials on using trilaciclib prior to treatment and the benefits of multi-lineage maintenance. If that wasn’t enough, the rintodestrant (its Selective Estrogen Receptor Degrader (SERD) under development to treat estrogen receptor-positive (ER) breast cancer) plus the palbociclib combination study was able to complete registration earlier than expected. the appeal of a purely oral regimen during a global pandemic, ”said Messer. With a data display planned for the second quarter of 2021, the analyst believes that a “positive display could prove to be a key value driver. In line with its optimistic approach, Messer reiterated a buy rating and a price target of USD 74, which indicates an upside potential of 417%. (To see Messer’s track record, click here. ) Do other analysts agree? you are. In the last three months only buy reviews have been given, to be precise 3. Hence the message is clear: GTHX is a strong buy. Given the average price target of $ 59, stocks could rise 312% over the next year. (See GTHX stock analysis on TipRanks) Epizym (EPZM) Epizym is also fighting in the fight against cancer and other serious diseases and aims to find new therapies through novel epigenetic drugs. While the company is facing headwinds with its recent product launch, several members of the street believe that big things are in store. Millenium bought 461 in the third quarter. 258 stocks, with the purchase reflecting a new position for the hedge fund. The value of the participation is 5. 503. 000 USD. 5-star analyst David Kidney Garden, who writes for Wedbush, points out that the pandemic has limited visits from oncologists and therefore Tazverik (the company’s treatment for follicular lymphoma) sales have been lower than expected. He points out that « the pandemic is shifting the starting curve to an incidence model rather than a prevalence model as there is a limited pool of patients available if they delay office visits, » with patients waiting for their treatment Seek treatment for symptoms of progression. Although the launch is virtual and doctor awareness is high, doctors refuse to prescribe a new drug without personally examining the patient. Even so, Kidney Garden remains optimistic about the therapy. “Despite this headwind, Tazverik is almost on our estimates and is gaining market share, including the first second-tier sales. We expect secondary line sales to begin in 2021 and have gradually added them to our launch curve, ”the analyst said. When it comes to therapy time, Kidney Garden believes it is too early to reach any conclusions. However, he emphasizes the fact that the duration of the response was relatively long and the patients in the registration study were treated as they progressed. “In addition, the headwind against switching therapies becomes a tailwind for Tazverik maintenance once a patient receives therapy. This will likely be a more significant contributor to 2H21’s sales and the potential outperformance of sales, ”he added. In summary, Kidney Garden said, “At current levels, we believe that investors are too negative about Tazverik’s potential and that patience should be rewarded. Based on all of the above, Kidney Garden takes the bulls’ side, reiterating an outperform rating and target price of $ 27. This goal conveys his confidence in the EPZM’s ability to grow 122% over the next year. (To see Kidney Garden’s success story, click here. Most of the other analysts share the opinion of Kidney Garden. 3 buys and 1 hold results in a strong buy consensus rating. With an average price target of $ 23. 25 the upside potential is 91%. (See EPZM stock analysis on TipRanks. ) To find great ideas for trading healthcare stocks at attractive valuations, visit TipRanks ‘Best Stocks to Buy,’ a newly launched tool that brings together all of the insights into TipRanks stocks. Disclaimer: The opinions expressed in this article are solely those of the presented analysts. The content is intended to be used for informational purposes only. It is very important that you do your own analysis before making any investment.

The year is drawing to a close and there is more and more positive news for the energy industry, presenting a range of juicy offers for this holiday season.

A home loan is a powerful financial tool even if you have the money to pay directly.

Nikola has ditched plans to build Badger’s electric pickup in a drastically reduced partnership deal with GM.

What is known as the « Universal Charitable Deduction » allows non-retailers to claim a tax break of up to $ 300 when they file their taxes in 2021. Charitable donations are tax deductible. However, taxpayers can only claim the deduction from their federal income tax if they state the deductible expenses. In addition to charitable donations, these expenses include medical expenses, mortgage interest, and state and local taxes (up to $ 10). 000 USD). .

President-elect Joe Biden announced Monday that he would appoint Janet Yellen, a former chairwoman of the Federal Reserve Bank, as his Treasury Secretary.

When looking for the best artificial intelligence stocks to buy, identify companies like Microsoft, Netflix, and Nvidia that are using AI technology to improve products or gain a strategic advantage.

Moderna stock hits new highs as the company prepares to launch its first product, a COVID-19 vaccine, by the end of the year.

Gold bulls remain under heavy pressure in the first trading session of the week in London.

You can inherit an IRA tax-free, but you could be fined 50% for not following the Rules on Minimum Required Distributions (RMDs). .

Shares in work intelligence company Slack Technologies rose Monday morning after reports that a deal to acquire the company by Salesforce could be announced as early as Tuesday after market close. CNBC reported that the deal is expected to be half cash and half stock, and values ​​Slack at a premium to current price. Salesforce stocks declined 3. 7% on $ 238. 90 on Monday.

Every week Benzinga conducts a sentiment survey to find out what traders are most excited about, what interests them or what they think about when managing and building their personal portfolios. We surveyed a group of over 300 investors on whether Nio (NYSE: NIO) or Xpeng (NYSE: XPEV) stocks would grow the most by 2025. About 67% of traders and investors said Nio’s shares would continue to grow over the next five years. Nio Vs. XPeng Stock In the short term, Shanghai-based EV maker Nio continues to attract investors’ attention amid significant earnings growth. Nio reported results above the consensus of the third quarter thanks to strong shipments and margin improvements. Sales increased by 146. 4% compared to the previous year and 21. 7% consecutively $ 666. 6 million. This corresponds to revenue of $ 262 last year. 47 million. The company also issued a strong outlook for the fourth quarter. Almost 33% of respondents said Xpeng stock would continue to grow over the next five years. One reader of our study expressed confidence that XPeng could establish itself as a leader in the emerging market for low-cost electric vehicles. Respondent noted how « XPeng, as a larger competitor to Tesla, is pursuing the larger, lower-cost market. Hence, they probably have the biggest 5 year chance as this huge segment of the market in China is both growing and moving to EV. «  » A good compact, low-cost EV product like the XPeng range would also gain momentum in Europe and the US as those regions switch to EVs more aggressively. « . Assuming they can continue to beat Tesla on price and offer comparable quality, XPeng could become Kia’s EV version when they first hit the market, « the interviewee said. This survey was conducted by Benzinga in November 2020 and included responses from a diverse population of adults aged 18 and over. Participation in the survey was entirely voluntary, with no incentives to potential respondents. The study reflects results from over 300 adults. See more from Benzinga * Click here for Benzinga option deals * Will Boeing or Airbus stock continue to grow through 2025? * Will Oracle or IBM stocks grow faster by 2025? (C) 2020 Benzinga. com. Benzinga does not offer investment advice. All rights reserved.

The rumors sparked last Thursday that Salesforce was interested in Slack. Chances are that this will be a large number, but this won’t be Salesforce’s first major acquisition. Salesforce already has over $ 20 billion in annual sales, and the company has done plenty of business in the past to fill the roadmap and boost the market as it seeks more revenue.

South Korea’s sovereign wealth fund sold shares in Alibaba, Apple and Intel in the third quarter. It has also more than doubled a position in GM stocks, a move that has paid off in the fourth quarter so far.

Loop analyst Ananda Baruah updated Apple and saw an upward trend in Mac, iPad and likely AirPod, Watch, and Services sales well into the 2021 calendar.

Real Estate Investment Trust, Cyber ​​Monday, Stock